SNDL Inc.

SNDL Inc. announced the successful completion of a European Union Good Manufacturing Practice (EU-GMP) audit at its Atholville, New Brunswick cultivation facility. This achievement reinforces SNDL’s ability to participate in regulated international medical cannabis markets and highlights its focus on quality and regulatory compliance. The company expects to receive EU-GMP certification within 90 days, strengthening Atholville's position as a key asset for international opportunities.

SNDL Inc. reported Q2 2026 financial results with net revenue decreasing 3.7% to $235.8 million and an operating loss of $(7.8) million, driven by market headwinds and production ramp-up costs. Despite negative cash flow, free cash flow improved year-over-year, and the company maintained a debt-free balance sheet with strong liquidity. A significant strategic milestone was the completion of the Parallel restructuring, which is expected to add US$150 million in annualized revenue and position SNDL as a leading vertically integrated cannabis operator in North America.

SNDL Inc. reported a net loss of $(7.8) million for Q2 2026, a decline from a net income of $2.9 million in Q2 2025, with net revenue decreasing to $235.8 million. The company announced the completion of the Parallel restructuring, gaining indirect majority economic exposure and expecting to assume direct control of U.S. medical cannabis operations. This positions SNDL to potentially become the first NASDAQ-listed company to consolidate U.S. medical cannabis operations.

SNDL Inc. announced the completion of its acquisition of certain assets from Parallel, a U.S. vertically integrated cannabis operator with operations in Florida, Texas, and Massachusetts. This strategic move provides SNDL with indirect majority economic exposure to Parallel's operations, which it expects to convert into direct, consolidated holdings, positioning it as one of the first Nasdaq-listed companies with direct exposure to U.S. medical cannabis. The transaction involved a strict foreclosure agreement, significantly reducing Parallel's legacy debt by approximately US$842 million and adding 56 retail locations and 3 cultivation facilities with US$150 million in annualized revenue to SNDL's portfolio.

SNDL Inc. announced it will release its second quarter 2026 financial results for the period ended June 30, 2026, before markets open on Tuesday, July 28, 2026. Following the release, the company will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on the same day to discuss the results.

SNDL Inc. announced it will release its second quarter 2026 financial results for the period ended June 30, 2026, before markets open on Tuesday, July 28, 2026. Following the release, the company will host a conference call and webcast at 10:00 a.m. EDT on the same day to discuss the results. Investors can access the live webcast via the provided link.

SNDL Inc. announced that its planned acquisition of 27 Ontario cannabis retail locations from 1CM Inc. for $27.2 million will not proceed. This decision follows a prolonged regulatory review process that extended beyond the commercially reasonable timelines. The company intends to reallocate the $27.2 million previously reserved for this acquisition towards its existing Share Repurchase Program, under which it has already repurchased over 5.5 million shares for approximately $11.1 million since March 31, 2026. The initial stage of the acquisition, involving five stores in Alberta and Saskatchewan, was completed and remains unaffected.

SNDL Inc. announced that its acquisition of the remaining 27 1CM Inc. Ontario cannabis retail locations, valued at $27.2 million, will not proceed. This decision follows a prolonged regulatory review process that extended beyond the commercially reasonable timelines and the May 31, 2026 outside date for provincial approvals. The first stage of the acquisition, involving five stores in Alberta and Saskatchewan, was completed on January 7, 2026, and remains unaffected. SNDL plans to reallocate the capital previously reserved for the Ontario acquisition towards its existing Share Repurchase Program, which authorizes up to $100 million in buybacks through November 20, 2026.

SNDL Inc. reported Q1 2026 net revenue of $195.9 million, a 4.4% decrease year-over-year, and an operating loss of $(9.1) million, an improvement of $2.9 million. The company maintained strong liquidity with $213.4 million in unrestricted cash and no debt, while repurchasing 4.5 million common shares. Strategic initiatives include the exclusive Canadian launch of the Jeeter cannabis brand and profit-enhancement efforts expected to add $20 million in operating income. Progress was also made on SunStream restructuring, and the recent US cannabis rescheduling is seen as a positive for the industry.

SNDL Inc. reported Q1 2026 net revenue of $195.9 million, a 4.4% decrease year-over-year, and a gross profit of $52.8 million, down 6.8%. The company posted an operating loss of $(9.1) million, an improvement of $2.9 million compared to the prior year, driven by the absence of prior-year valuation reductions and restructuring charges. Market headwinds in both Liquor and Cannabis segments impacted performance. SNDL also repurchased 4.5 million common shares during the quarter and is implementing profit-enhancement initiatives and advancing SunStream restructuring.